Global, regional, and national burden of gout, 1990-2021: an analysis of the global burden of disease study 2021
DOI:
https://doi.org/10.54103/2282-0930/30070Keywords:
decomposition analysis, frontier analysis, global disease burden, goutAbstract
Aim: The global incidence rate of gout has shown a consistent increase, requiring an in-depth study of potential risk factors at the national and regional levels. This study uses data from the 2021 Global Burden of Disease, Injury, and Risk Factors Study to analyze the incidence trend of gout, in order to reveal the global disease burden of gout and provide a basis for optimizing prevention and control strategies for healthcare systems.
Subject and Methods: This study collected data on gout from 1990 to 2021. Conduct decomposition analysis and frontier analysis to determine the changing trends of various indicators and their influencing factors.
Results: According to global data in 2021, the number of incidence cases of gout reached 9,401,585 (95% uncertainty interval [UI]: 7,438,817-11,731,815 cases), and the number of prevalence cases was 56,474,572 (95% UI: 45,161,987-70,288,316 cases). The number of cases of DALYs was 1,747,546 (95% UI: 1,186,175-2,484,547 cases), an increase by 17.15-21.86% since 1990. Further analysis of the data from 1990 to 2021 showed that the estimated annual percentage changes (EAPCs) of the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized disability-adjusted life-year rate (ASDR) were 0.67 (95% UI: 0.61-0.73), 0.87 (95% UI: 0.8-0.95), and 0.86 (95% UI: 0.78-0.93), respectively. There were more male cases than female cases, and the growth rate was higher in males than in females. However, the rising trend of the global incidence and disability burden of gout in women needs attention.
Conclusion: With social progress, the burden of gout increases, mainly due to population growth and aging. Gout is associated with a high body mass index. Weight loss diets and lifestyle adjustments need to be promoted to reduce health burdens and prevent recurrences.
Downloads
References
Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016;388(10055):2039-52.
Fu T, Cao H, Yin R, Zhang L, Zhang Q, Li L, et al. Associated factors with functional disability and health-related quality of life in Chinese patients with gout: a case-control study. BMC Musculoskelet Disord. 2017;18(1):429.
Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11(11):649-62.
Butler F, Alghubayshi A, Roman Y. The Epidemiology and Genetics of Hyperuricemia and Gout across Major Racial Groups: A Literature Review and Population Genetics Secondary Database Analysis. J Pers Med. 2021;11(3).
Punzi L, Scanu A, Galozzi P, Luisetto R, Spinella P, Scirè CA, et al. One year in review 2020: gout. Clin Exp Rheumatol. 2020;38(5):807-21.
Stamp LK, Chapman PT. Gout and its comorbidities: implications for therapy. Rheumatology (Oxford). 2013;52(1):34-44.
Pillinger MH, Goldfarb DS, Keenan RT. Gout and its comorbidities. Bull NYU Hosp Jt Dis. 2010;68(3):199-203.
Smith E, Hoy D, Cross M, Merriman TR, Vos T, Buchbinder R, et al. The global burden of gout: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(8):1470-6.
Singh JA, Reddy SG, Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol. 2011;23(2):192-202.
Rezapour A, Alidoost S, Asgharzadeh A, Farhadi Z, Khodadadi N, Mohammadi Bakhsh R, et al. Cost-effectiveness of allopurinol versus febuxostat in the treatment of gout patients: A systematic review. Med J Islam Repub Iran. 2020;34:41.
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England) 2020;396:1204-22.
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133-61.
Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest. 2010;40(1):35-53.
Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20(3):895-900.
Yang X, Chen H, Zhang T, Yin X, Man J, He Q, et al. Global, regional, and national burden of blindness and vision loss due to common eye diseases along with its attributable risk factors from 1990 to 2019: a systematic analysis from the global burden of disease study 2019. Aging (Albany NY). 2021;13(15):19614-42.
Zhai Z, Ruan J, Zheng Y, Xiang D, Li N, Hu J, et al. Assessment of Global Trends in the Diagnosis of Mesothelioma From 1990 to 2017. JAMA Netw Open. 2021;4(8):e2120360.
Das Gupta P. A general method of decomposing a difference between two rates into several components. Demography. 1978;15(1):99-112.
Ruan R, Liu X, Zhang Y, Tang M, He B, Zhang QW, et al. Global, Regional, and National Advances Toward the Management of Rheumatic Heart Disease Based on the Global Burden of Disease Study 2019. J Am Heart Assoc. 2023;12(13):e028921.
Safiri S, Kolahi AA, Cross M, Carson-Chahhoud K, Hoy D, Almasi-Hashiani A, et al. Prevalence, Incidence, and Years Lived With Disability Due to Gout and Its Attributable Risk Factors for 195 Countries and Territories 1990-2017: A Systematic Analysis of the Global Burden of Disease Study 2017. Arthritis Rheumatol. 2020;72(11):1916-27.
Guillén AG, Te Karu L, Singh JA, Dalbeth N. Gender and Ethnic Inequities in Gout Burden and Management. Rheum Dis Clin North Am. 2020;46(4):693-703.
Xia Y, Wu Q, Wang H, Zhang S, Jiang Y, Gong T, et al. Global, regional and national burden of gout, 1990-2017: a systematic analysis of the Global Burden of Disease Study. Rheumatology (Oxford). 2020;59(7):1529-38.
Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011;63(10):3136-41.
Choi HK, McCormick N, Yokose C. Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care. Nat Rev Rheumatol. 2022;18(2):97-111.
Mattiuzzi C, Lippi G. Recent updates on worldwide gout epidemiology. Clin Rheumatol. 2020;39(4):1061-3.
Te Kampe R, Janssen M, van Durme C, Jansen TL, Boonen A. Sex Differences in the Clinical Profile Among Patients With Gout: Cross-sectional Analyses of an Observational Study. J Rheumatol. 2021;48(2):286-92.
Harrold LR, Etzel CJ, Gibofsky A, Kremer JM, Pillinger MH, Saag KG, et al. Sex differences in gout characteristics: tailoring care for women and men. BMC Musculoskelet Disord. 2017;18(1):108.
McCormick N, Yokose C, Lu N, Joshi AD, Curhan GC, Choi HK. Impact of adiposity on risk of female gout among those genetically predisposed: sex-specific prospective cohort study findings over >32 years. Ann Rheum Dis. 2022;81(4):556-63.
McCormick N, Rai SK, Lu N, Yokose C, Curhan GC, Choi HK. Estimation of Primary Prevention of Gout in Men Through Modification of Obesity and Other Key Lifestyle Factors. JAMA Netw Open. 2020;3(11):e2027421.
Choi HK, McCormick N, Lu N, Rai SK, Yokose C, Zhang Y. Population Impact Attributable to Modifiable Risk Factors for Hyperuricemia. Arthritis Rheumatol. 2020;72(1):157-65.
Fam AG. Gout, diet, and the insulin resistance syndrome. J Rheumatol. 2002;29(7):1350-5.
Emmerson BT. The management of gout. N Engl J Med. 1996;334(7):445-51.
Emmerson BT. Alteration of urate metabolism by weight reduction. Aust N Z J Med. 1973;3(4):410-2.
Modan M, Halkin H, Fuchs Z, Lusky A, Chetrit A, Segal P, et al. Hyperinsulinemia--a link between glucose intolerance, obesity, hypertension, dyslipoproteinemia, elevated serum uric acid and internal cation imbalance. Diabete Metab. 1987;13(3 Pt 2):375-80.
Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. Jama. 1991;266(21):3008-11.
Yamashita S, Matsuzawa Y, Tokunaga K, Fujioka S, Tarui S. Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes. 1986;10(4):255-64.
Yokose C, McCormick N, Rai SK, Lu N, Curhan G, Schwarzfuchs D, et al. Effects of Low-Fat, Mediterranean, or Low-Carbohydrate Weight Loss Diets on Serum Urate and Cardiometabolic Risk Factors: A Secondary Analysis of the Dietary Intervention Randomized Controlled Trial (DIRECT). Diabetes Care. 2020;43(11):2812-20.
Maglio C, Peltonen M, Neovius M, Jacobson P, Jacobsson L, Rudin A, et al. Effects of bariatric surgery on gout incidence in the Swedish Obese Subjects study: a non-randomised, prospective, controlled intervention trial. Ann Rheum Dis. 2017;76(4):688-93.
Lu J, Bai Z, Chen Y, Li Y, Tang M, Wang N, et al. Effects of bariatric surgery on serum uric acid in people with obesity with or without hyperuricaemia and gout: a retrospective analysis. Rheumatology (Oxford). 2021;60(8):3628-34.
Acheson RM. Epidemiology of serum uric acid and gout: an example of the complexities of multifactorial causation. Proc R Soc Med. 1970;63(2):193-7.
Gibson T, Waterworth R, Hatfield P, Robinson G, Bremner K. Hyperuricaemia, gout and kidney function in New Zealand Maori men. Br J Rheumatol. 1984;23(4):276-82.
Roubenoff R, Klag MJ, Mead LA, Liang KY, Seidler AJ, Hochberg MC. Incidence and risk factors for gout in white men. Jama. 1991;266(21):3004-7.
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-33.
Evans PL, Prior JA, Belcher J, Mallen CD, Hay CA, Roddy E. Obesity, hypertension and diuretic use as risk factors for incident gout: a systematic review and meta-analysis of cohort studies. Arthritis Res Ther. 2018;20(1):136.
Maynard JW, McAdams-DeMarco MA, Law A, Kao L, Gelber AC, Coresh J, et al. Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2014;179(5):576-83.
Thompson MD, Wu YY, Cooney RV, Wilkens LR, Haiman CA, Pirkle CM. Modifiable Factors and Incident Gout Across Ethnicity Within a Large Multiethnic Cohort of Older Adults. J Rheumatol. 2022;49(5):504-12.
Hochberg MC, Thomas J, Thomas DJ, Mead L, Levine DM, Klag MJ. Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum. 1995;38(5):628-32.
Singh JA, Bharat A, Khanna D, Aquino-Beaton C, Persselin JE, Duffy E, et al. Racial differences in health-related quality of life and functional ability in patients with gout. Rheumatology (Oxford). 2017;56(1):103-12.
Krishnan E. Gout in African Americans. Am J Med. 2014;127(9):858-64.
Norton JM, Moxey-Mims MM, Eggers PW, Narva AS, Star RA, Kimmel PL, et al. Social Determinants of Racial Disparities in CKD. J Am Soc Nephrol. 2016;27(9):2576-95.
Evans K, Coresh J, Bash LD, Gary-Webb T, Köttgen A, Carson K, et al. Race differences in access to health care and disparities in incident chronic kidney disease in the US. Nephrol Dial Transplant. 2011;26(3):899-908.
Johnson RJ, Rideout BA. Uric acid and diet--insights into the epidemic of cardiovascular disease. N Engl J Med. 2004;350(11):1071-3.
Yokose C, McCormick N, Lu N, Joshi AD, Curhan G, Choi HK. Adherence to 2020 to 2025 Dietary Guidelines for Americans and the Risk of New-Onset Female Gout. JAMA Intern Med. 2022;182(3):254-64.
Berkowitz SA, Curran N, Hoeffler S, Henderson R, Price A, Ng SW. Association of a Fruit and Vegetable Subsidy Program With Food Purchases by Individuals With Low Income in the US. JAMA Netw Open. 2021;4(8):e2120377.
Fang Zhang F, Liu J, Rehm CD, Wilde P, Mande JR, Mozaffarian D. Trends and Disparities in Diet Quality Among US Adults by GBD 2019 Diseases and Injuries Collaborators. Global burden of 302 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–22.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Fangfang Deng, Fan Hu, Huali Guo, Bo Chen
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
